Cash flow CorMedix Inc.

Stocks

CRMD

US21900C3088

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 01:30:00 18/07/2026 am IST			5-day change	1st Jan Change
8.420 ^USD	+1.57%		+0.24%	-27.60%

07/07	RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating	MT
03/07	CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer	MT

f47d7615635bd9a4469d4dd714b.uv60P4uRQ9O9sA-YGC_tqGss3X01ehELnI3pBYaqqTE.1MfDU7KoLbfwg0G1b0aI4zxLtTZnLlhPyOmPT7LQnEjtrN4Pv8kvldX9Qg

Published financial data: CORMEDIX INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	2L	65.41T	-	4.35Cr	31Cr
Total Revenues	2L	65.41T	-	4.35Cr	31Cr
Cost of Goods Sold, Total	1L	3.73T	-	31.91L	2.21Cr
Gross Profit	42T	61.67T	-	4.03Cr	29Cr
Selling General & Admin Expenses, Total	1.63Cr	2Cr	3.58Cr	5.87Cr	9.61Cr
R&D Expenses	1.31Cr	1.07Cr	1.32Cr	39.42L	1.93Cr
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	1.39Cr
Other Operating Expenses, Total	2.95Cr	3.07Cr	4.9Cr	6.26Cr	13Cr
Operating Income	-2.94Cr	-3.06Cr	-4.9Cr	-2.24Cr	16Cr
Interest Expense, Total	-15.94T	-26.52T	-34.3T	-36.4T	-27.82L
Interest And Investment Income	14.4T	3L	26.82L	25.79L	38.46L
Net Interest Expenses	-1.54T	3L	26.48L	25.42L	10.64L
Currency Exchange Gains (Loss)	-21.29T	37.14T	-28.99T	-30.79T	-52T
Other Non Operating Income (Expenses)	-	-	-	5L	-
EBT, Excl. Unusual Items	-2.95Cr	-3.03Cr	-4.63Cr	-1.93Cr	16Cr
Merger & Related Restructuring Charges	-	-	-	-	-1.02Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	53.64L
Other Unusual Items	-	-	-	-	-65.01L
EBT, Incl. Unusual Items	-2.95Cr	-3.03Cr	-4.63Cr	-1.93Cr	15Cr
Income Tax Expense	-12.5L	-6L	-	-13.95L	-1.3Cr
Earnings From Continuing Operations	-2.82Cr	-2.97Cr	-4.63Cr	-1.79Cr	16Cr
Net Income to Company	-2.82Cr	-2.97Cr	-4.63Cr	-1.79Cr	16Cr
Net Income - (IS)	-2.82Cr	-2.97Cr	-4.63Cr	-1.79Cr	16Cr
Preferred Dividend and Other Adjustments	-	-	-	-	10L
Net Income to Common Incl Extra Items	-2.82Cr	-2.97Cr	-4.63Cr	-1.79Cr	16Cr
Net Income to Common Excl. Extra Items	-2.82Cr	-2.97Cr	-4.63Cr	-1.79Cr	16Cr
Per Share Items
Net EPS - Basic	-0.75	-0.74	-0.91	-0.3	2.25
Basic EPS - Continuing Operations	-0.75	-0.74	-0.91	-0.3	2.25
Basic Weighted Average Shares Outstanding	3.77Cr	4.03Cr	5.09Cr	5.89Cr	7.2Cr
Net EPS - Diluted	-0.75	-0.74	-0.91	-0.3	2.04
Diluted EPS - Continuing Operations	-0.75	-0.74	-0.91	-0.3	2.04
Diluted Weighted Average Shares Outstanding	3.77Cr	4.03Cr	5.09Cr	5.89Cr	8.03Cr
Normalized Basic EPS	-0.49	-0.47	-0.57	-0.21	1.4
Normalized Diluted EPS	-0.49	-0.47	-0.57	-0.21	1.26
Supplemental Items
EBITDA	-2.94Cr	-3.05Cr	-4.89Cr	-2.2Cr	17Cr
EBITA	-2.94Cr	-3.06Cr	-4.9Cr	-2.22Cr	17Cr
EBIT	-2.94Cr	-3.06Cr	-4.9Cr	-2.24Cr	16Cr
EBITDAR	-2.92Cr	-3.03Cr	-4.87Cr	-2.18Cr	-
Total Revenues (As Reported)	-	-	-	-	31Cr
Effective Tax Rate - (Ratio)	4.24	1.93	-	7.22	-8.69
Current Domestic Taxes	-	-	-	-	1.28Cr
Total Current Taxes	-	-	-	-	1.28Cr
Deferred Domestic Taxes	-	-	-	-	-2.58Cr
Total Deferred Taxes	-	-	-	-	-2.58Cr
Normalized Net Income	-1.84Cr	-1.89Cr	-2.9Cr	-1.21Cr	10Cr
Interest on Long-Term Debt	15.94T	26.52T	34.3T	-	-
Non-Cash Pension Expense	-	-	-	-	41L
Supplemental Operating Expense Items
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	-	-	-	2.87Cr	3.81Cr
General and Administrative Expenses	-	-	-	3Cr	5.8Cr
Research And Development Expense From Footnotes	1.31Cr	1.07Cr	1.32Cr	39.42L	1.93Cr
Net Rental Expense, Total	2L	2L	2L	2L	-
Imputed Operating Lease Interest Expense	27.25T	51.12T	77.27T	1L	-
Imputed Operating Lease Depreciation	2L	2L	1L	1L	-
Stock-Based Comp., COGS (Total)	-	-	-	-	5L
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	7L
Stock-Based Comp., S&M Exp. (Total)	-	-	-	-	16.9L
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	1.09Cr
Stock-Based Comp., Other (Total)	50.43L	40.7L	54.94L	61.29L	-
Total Stock-Based Compensation	50.43L	40.7L	54.94L	61.29L	1.38Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	5.33Cr	4.31Cr	4.36Cr	4.07Cr	14Cr
Short Term Investments	1.21Cr	1.56Cr	3.24Cr	1.1Cr	36.94L
Total Cash And Short Term Investments	6.55Cr	5.88Cr	7.6Cr	5.17Cr	15Cr
Accounts Receivable, Total	45.37T	-	-	5.17Cr	17Cr
Total Receivables	45.37T	-	-	5.17Cr	17Cr
Inventory	3.01T	-	21.06L	76L	2.97Cr
Prepaid Expenses	8L	6L	9L	33.9L	1.69Cr
Restricted Cash	1L	1L	77.45T	-	7L
Other Current Assets, Total	51.99T	11.02T	4L	2L	-
Total Current Assets	6.65Cr	5.96Cr	7.95Cr	11Cr	37Cr
Gross Property Plant And Equipment	27.4L	28.35L	30.27L	29.95L	-
Accumulated Depreciation	-4L	-4L	-5L	-7L	-
Net Property Plant And Equipment	23.74L	23.85L	25.07L	23.21L	99.25L
Long-term Investments	-	-	-	-	1.04Cr
Goodwill	-	-	-	-	3Cr
Other Intangibles, Total	-	-	-	18.44L	38Cr
Deferred Tax Assets Long-Term	-	-	-	-	1.63Cr
Other Long-Term Assets, Total	1L	1L	1L	1L	1.35Cr
Total Assets	6.89Cr	6.2Cr	8.21Cr	12Cr	83Cr
Liabilities
Accounts Payable, Total	22.1L	22.02L	42.8L	17.2L	78.84L
Accrued Expenses, Total	30.14L	39.74L	69.7L	3Cr	15Cr
Current Portion of Leases	1L	1L	2L	2L	14.49L
Current Income Taxes Payable	-	-	-	-	1.28Cr
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	-	-	-	20L	38.19L
Total Current Liabilities	53.45L	63.11L	1.14Cr	3.38Cr	17Cr
Long-Term Debt	-	-	-	-	14Cr
Long-Term Leases	8L	7L	5L	3L	28.39L
Other Non Current Liabilities	-	-	-	-	9.91Cr
Total Liabilities	61.48L	69.79L	1.19Cr	3.42Cr	42Cr
Preferred Stock Convertible	182	182	182	137	-
Total Preferred Equity	182	182	182	137	-
Common Stock, Total	38.09T	42.82T	54.94T	64.41T	79T
Additional Paid In Capital	31Cr	33Cr	39Cr	42Cr	58Cr
Retained Earnings	-25Cr	-28Cr	-32Cr	-34Cr	-18Cr
Comprehensive Income and Other	87.13T	82.74T	94.11T	90.65T	3T
Total Common Equity	6.28Cr	5.51Cr	7.01Cr	8.47Cr	41Cr
Total Equity	6.28Cr	5.51Cr	7.01Cr	8.47Cr	41Cr
Total Liabilities And Equity	6.89Cr	6.2Cr	8.21Cr	12Cr	83Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.87Cr	4.45Cr	5.5Cr	6.52Cr	7.91Cr
ECS Total Common Shares Outstanding	3.81Cr	4.28Cr	5.49Cr	6.44Cr	7.93Cr
Book Value / Share	1.65	1.29	1.28	1.31	5.11
Tangible Book Value	6.28Cr	5.51Cr	7.01Cr	8.28Cr	-37.67L
Tangible Book Value Per Share	1.65	1.29	1.28	1.29	-0.05
Total Debt	9L	8L	7L	5L	15Cr
Net Debt	-6.45Cr	-5.8Cr	-7.54Cr	-5.12Cr	-99.81L
Debt Equivalent Oper. Leases	16.72L	16.64L	16.56L	16.32L	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	-	-	15.25L	11.11L	36.35L
Inventories - Work In Process, Total	-	-	6L	35.28L	1.17Cr
Inventories - Finished Goods, Total	3.01T	-	-	29.6L	1.44Cr
Full Time Employees	29	40	82	64	191
Part Time Employees	1	1	1	1	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-2.82Cr	-2.97Cr	-4.63Cr	-1.79Cr	16Cr
Depreciation & Amortization - CF	61.89T	84.62T	70.76T	2L	7L
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	2L	1.39Cr
Depreciation & Amortization, Total	61.89T	84.62T	70.76T	3L	1.45Cr
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	4L
(Gain) Loss From Sale Of Asset	-	-	-	-	-86T
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-53.64L
Stock-Based Compensation (CF)	50.43L	40.7L	54.94L	61.29L	1.38Cr
Provision and Write-off of Bad Debts	-	-	-	1L	3L
Other Operating Activities, Total	1L	1L	1L	1L	-1.89Cr
Change In Accounts Receivable	-44.08T	42.14T	-	-5.18Cr	-9.09Cr
Change In Inventories	1L	3.01T	-21.06L	-54.93L	-34.78L
Change In Accounts Payable	10.82L	-6.57T	20.77L	-25.59L	33.29L
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	7L	10.28L	22.59L	2.04Cr	9.83Cr
Cash from Operations	-2.12Cr	-2.44Cr	-3.84Cr	-5.06Cr	18Cr
Capital Expenditure	-14.25L	-2L	-3L	-1L	-22.6L
Cash Acquisitions	-	-	-	-	-31Cr
Investment in Marketable and Equity Securities, Total	-77.1L	-34.9L	-1.67Cr	2.13Cr	23.41L
Cash from Investing	-91.35L	-37.09L	-1.71Cr	2.12Cr	-31Cr
Long-Term Debt Issued, Total	-	-	-	-	15Cr
Total Debt Issued	-	-	-	-	15Cr
Long-Term Debt Repaid, Total	-	-	-	-	-2L
Total Debt Repaid	-	-	-	-	-2L
Issuance of Common Stock	4.18Cr	1.79Cr	5.61Cr	2.66Cr	9.65Cr
Repurchase of Common Stock	-	-	-2L	-3L	-19.88L
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-59.18L
Cash from Financing	4.18Cr	1.79Cr	5.59Cr	2.63Cr	24Cr
Foreign Exchange Rate Adjustments	-12.92T	-8.68T	2.81T	-1.71T	-
Net Change in Cash	1.15Cr	-1.02Cr	4L	-30.67L	11Cr
Supplemental Items
Cash Interest Paid	15.94T	26.52T	34.3T	36.4T	17T
Levered Free Cash Flow	-1.27Cr	-1.4Cr	-2.3Cr	-4.47Cr	11Cr
Unlevered Free Cash Flow	-1.27Cr	-1.4Cr	-2.29Cr	-4.47Cr	11Cr
Change In Net Working Capital	-20.01L	-11.96L	-24.13L	3.7Cr	1.65Cr
Net Debt Issued / Repaid	-	-	-	-	15Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-31.12	-29.22	-42.47	-13.91	21.21
Return on Total Capital	-33.77	-32.01	-48.31	-17.92	31.35
Return On Equity %	-52.72	-50.4	-74.02	-23.17	66.56
Return on Common Equity	-52.72	-50.4	-74.02	-23.17	66.15
Margin Analysis
Gross Profit Margin %	22	94.29	-	92.66	92.91
SG&A Margin	8.56T	30.59T	-	135.02	30.82
EBITDA Margin %	-15.39T	-46.69T	-	-50.71	56.11
EBITA Margin %	-15.42T	-46.82T	-	-51.07	55.89
EBIT Margin %	-15.42T	-46.82T	-	-51.43	51.44
Income From Continuing Operations Margin %	-14.77T	-45.41T	-	-41.24	52.31
Net Income Margin %	-14.77T	-45.41T	-	-41.24	52.31
Net Avail. For Common Margin %	-14.77T	-45.41T	-	-41.24	51.99
Normalized Net Income Margin	-9.64T	-28.94T	-	-27.78	32.35
Levered Free Cash Flow Margin	-6.67T	-21.44T	-	-102.87	34.81
Unlevered Free Cash Flow Margin	-6.66T	-21.42T	-	-102.81	35.24
Asset Turnover
Asset Turnover	0	0	-	0.43	0.66
Fixed Assets Turnover	0.11	0.03	-	18.01	50.9
Receivables Turnover (Average Receivables)	7.84	-	-	-	2.8
Inventory Turnover (Average Inventory)	2.03	-	-	0.66	1.18
Short Term Liquidity
Current Ratio	12.44	9.44	6.97	3.39	2.11
Quick Ratio	12.26	9.32	6.67	3.05	1.83
Operating Cash Flow to Current Liabilities	-3.96	-3.86	-3.37	-1.5	1
Days Sales Outstanding (Average Receivables)	46.57	-	-	-	130.5
Days Outstanding Inventory (Average Inventory)	179.6	-	-	556.7	308.31
Average Days Payable Outstanding	72.67T	-	-	126.44	39.65
Cash Conversion Cycle (Average Days)	-72.44T	-	-	-	399.15
Long Term Solvency
Total Debt/Equity	1.47	1.46	0.95	0.61	36.74
Total Debt / Total Capital	1.45	1.44	0.94	0.61	26.87
LT Debt/Equity	1.28	1.21	0.74	0.41	36.38
Long-Term Debt / Total Capital	1.26	1.2	0.73	0.41	26.61
Total Liabilities / Total Assets	8.92	11.25	14.52	28.77	50.94
EBIT / Interest Expense	-1.85T	-1.15T	-1.43T	-614.1	57.64
EBITDA / Interest Expense	-1.83T	-1.14T	-1.42T	-599.99	62.96
(EBITDA - Capex) / Interest Expense	-1.92T	-1.15T	-1.43T	-603.17	62.15
Total Debt / EBITDA	-0.03	-0.03	-0.01	-0.02	0.85
Net Debt / EBITDA	2.21	1.91	1.55	2.34	-0.06
Total Debt / (EBITDA - Capex)	-0.03	-0.03	-0.01	-0.02	0.86
Net Debt / (EBITDA - Capex)	2.11	1.9	1.54	2.33	-0.06
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-20.19	-65.74	-	-	617.03
Gross Profit, 1 Yr. Growth %	22.14	46.85	-	-	616.21
EBITDA, 1 Yr. Growth %	8.43	3.96	60.08	-54.9	-893.3
EBITA, 1 Yr. Growth %	8.14	4.03	59.87	-54.65	-884.74
EBIT, 1 Yr. Growth %	8.14	4.03	59.87	-54.34	-817.22
Earnings From Cont. Operations, 1 Yr. Growth %	28.07	5.29	56.02	-61.31	-1.01T
Net Income, 1 Yr. Growth %	28.07	5.29	56.02	-61.31	-1.01T
Normalized Net Income, 1 Yr. Growth %	8.32	2.81	53	-58.3	-934.94
Diluted EPS Before Extra, 1 Yr. Growth %	-2.89	-1.53	23.44	-66.54	-769.82
Accounts Receivable, 1 Yr. Growth %	1.25T	-	-	-	231.5
Inventory, 1 Yr. Growth %	-97.9	-	-	260.79	291
Net Property, Plant and Equip., 1 Yr. Growth %	110.85	0.43	5.1	-7.41	327.43
Total Assets, 1 Yr. Growth %	39.83	-10.02	32.27	44.83	595.14
Tangible Book Value, 1 Yr. Growth %	42	-12.32	27.39	18.06	-104.55
Common Equity, 1 Yr. Growth %	42	-12.32	27.39	20.69	378.76
Cash From Operations, 1 Yr. Growth %	-3.7	15.13	57.7	31.78	-445.84
Capital Expenditures, 1 Yr. Growth %	1.17T	-84.61	49.21	-64.64	1.85T
Levered Free Cash Flow, 1 Yr. Growth %	-25.34	10.2	63.77	94.68	-342.65
Unlevered Free Cash Flow, 1 Yr. Growth %	-25.3	10.15	63.81	94.77	-345.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-17.9	-47.71	-	2.48T	-
Gross Profit, 2 Yr. CAGR %	-31.68	33.93	-	2.46T	-
EBITDA, 2 Yr. CAGR %	18.46	6.17	29	-15.03	89.14
EBITA, 2 Yr. CAGR %	18.38	6.07	28.96	-14.86	88.64
EBIT, 2 Yr. CAGR %	18.38	6.07	28.96	-14.56	80.97
Earnings From Cont. Operations, 2 Yr. CAGR %	31.02	16.12	28.17	-22.3	87.58
Net Income, 2 Yr. CAGR %	31.02	16.12	28.17	-22.3	87.58
Normalized Net Income, 2 Yr. CAGR %	17.07	5.53	25.42	-20.12	86.6
Diluted EPS Before Extra, 2 Yr. CAGR %	-35.54	-2.21	10.25	-35.74	49.7
Accounts Receivable, 2 Yr. CAGR %	3.5T	-	-	-	-
Inventory, 2 Yr. CAGR %	-90.57	-	2.55T	-	275.6
Net Property, Plant and Equip., 2 Yr. CAGR %	332.7	45.52	2.74	-1.35	98.99
Total Assets, 2 Yr. CAGR %	52.94	12.17	9.1	38.41	217.29
Tangible Book Value, 2 Yr. CAGR %	62.96	11.58	5.69	22.64	-76.83
Common Equity, 2 Yr. CAGR %	62.96	11.58	5.69	24	140.38
Cash From Operations, 2 Yr. CAGR %	18.55	5.3	34.74	44.15	113.48
Capital Expenditures, 2 Yr. CAGR %	524.29	39.55	-52.08	-27.37	162.77
Levered Free Cash Flow, 2 Yr. CAGR %	0.07	-9.29	34.34	78.56	117.35
Unlevered Free Cash Flow, 2 Yr. CAGR %	0.74	-9.29	34.33	78.62	118.79
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-23.7	-38.65	-	510.62	1.58T
Gross Profit, 3 Yr. CAGR %	8.36	-11.83	-	886.19	1.57T
EBITDA, 3 Yr. CAGR %	3.12	13.41	21.74	-9.12	78.91
EBITA, 3 Yr. CAGR %	3.1	13.39	21.61	-8.98	78.51
EBIT, 3 Yr. CAGR %	3.1	13.39	21.61	-8.76	73.64
Earnings From Cont. Operations, 3 Yr. CAGR %	1.69	21.81	28.13	-14.02	76.41
Net Income, 3 Yr. CAGR %	1.69	21.81	28.13	-14.02	76.41
Normalized Net Income, 3 Yr. CAGR %	3.17	12.11	19.44	-13.11	74.65
Diluted EPS Before Extra, 3 Yr. CAGR %	-20.77	-25.76	5.68	-25.91	40.38
Accounts Receivable, 3 Yr. CAGR %	60.84	-	-	944.2	-
Inventory, 3 Yr. CAGR %	-80.85	-	144.81	1.26T	-
Net Property, Plant and Equip., 3 Yr. CAGR %	145.3	165.92	30.56	-0.76	60.85
Total Assets, 3 Yr. CAGR %	54.14	28.15	18.51	19.9	137.03
Tangible Book Value, 3 Yr. CAGR %	133.48	32.54	16.62	9.66	-59.1
Common Equity, 3 Yr. CAGR %	133.48	32.54	16.62	10.47	94.53
Cash From Operations, 3 Yr. CAGR %	-3.72	17.4	20.47	33.75	92.98
Capital Expenditures, 3 Yr. CAGR %	207.77	81.69	42.7	-56.7	117.6
Levered Free Cash Flow, 3 Yr. CAGR %	-2.84	3.34	10.45	52.02	97.78
Unlevered Free Cash Flow, 3 Yr. CAGR %	-2.86	3.79	10.46	52.04	98.67
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-3.15	-27.62	-	173.66	319.75
Gross Profit, 5 Yr. CAGR %	-21.69	-22.05	-	239	509.67
EBITDA, 5 Yr. CAGR %	3.5	-1.47	12.78	1.04	45.21
EBITA, 5 Yr. CAGR %	3.52	-1.44	12.75	1.11	44.96
EBIT, 5 Yr. CAGR %	3.52	-1.44	12.75	1.25	42.57
Earnings From Cont. Operations, 5 Yr. CAGR %	2.74	-2.09	11.55	1.76	49.24
Net Income, 5 Yr. CAGR %	2.74	-2.09	11.55	1.76	49.24
Normalized Net Income, 5 Yr. CAGR %	3.64	-1.71	11.55	-2.11	42.77
Diluted EPS Before Extra, 5 Yr. CAGR %	-25.42	-24.43	-9.58	-29.93	21.48
Accounts Receivable, 5 Yr. CAGR %	30.44	-	-	1.61T	774.03
Inventory, 5 Yr. CAGR %	-55.2	-	37.5	86.32	190.53
Net Property, Plant and Equip., 5 Yr. CAGR %	102.52	66.52	73.19	78.85	54.54
Total Assets, 5 Yr. CAGR %	25.77	35.76	34.24	32.16	75.72
Tangible Book Value, 5 Yr. CAGR %	28.66	50.24	70.04	28.49	-38.9
Common Equity, 5 Yr. CAGR %	28.66	50.24	70.04	29.06	55.75
Cash From Operations, 5 Yr. CAGR %	-1.02	-3.15	10.14	27.45	51.45
Capital Expenditures, 5 Yr. CAGR %	89.24	7.61	46.26	25.91	82.17
Levered Free Cash Flow, 5 Yr. CAGR %	-0.63	-3.11	10.6	28.61	44.8
Unlevered Free Cash Flow, 5 Yr. CAGR %	-0.65	-3.13	10.59	28.96	45.19